Kolexia
Abdi Basma
Pharmacien
Hôpital Pitie Salpetriere
Paris, France
57 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Infections à VIH Sclérose en plaques Sclérose Virémie Neuromyélite optique Infections à coronavirus Maladie de Parkinson Lymphomes

Industries

Adliva
23 collaboration(s)
Dernière en 2021
ViiV Healthcare
11 collaboration(s)
Dernière en 2023
MSD
10 collaboration(s)
Dernière en 2023
Abbott
3 collaboration(s)
Dernière en 2023

Dernières activités

Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES): Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
Essai Clinique (Assistance publique – Hôpitaux de Paris)   01 février 2024
Unlocking antiretroviral treatment potential: Use of doravirine (DOR) in PLHIV with past NNRTI resistance associated mutations (RAMs)
HIV medicine Congress 2023   01 décembre 2023
Dolutegravir/rilpivirine (DTG/RPV) therapy as a maintenance treatment in PLWH with past virological failures and resistance-associated mutations to NNRTIs and INSTIs
HIV medicine Congress 2023   01 décembre 2023
HIV viremias among patients who discontinued Cabotegravir (CAB)/Rilpivirine (RPV) Long acting (LA) intramuscular (IM) in real-life setting
HIV medicine Congress 2023   01 décembre 2023
Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study.
The Journal of antimicrobial chemotherapy   03 août 2023
Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?
Journal of neurology, neurosurgery, and psychiatry   21 juillet 2023
Intermittent doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) maintains a high level of viral suppression in virologically suppressed people living with HIV.
Infectious diseases now   14 juin 2023
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
The Journal of antimicrobial chemotherapy   02 juin 2023
Vaccination contre le SARS-CoV-2 avant l’introduction d’un traitement par anti-CD20 chez les patients atteints de sclérose en plaques : une protection durable ?
Journées de Neurologie de Langue Française 2023   01 avril 2023
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.
Journal of personalized medicine   27 mars 2023